78 related articles for article (PubMed ID: 9690622)
1. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.
McKenzie PP; Guichard SM; Middlemas DS; Ashmun RA; Danks MK; Harris LC
Clin Cancer Res; 1999 Dec; 5(12):4199-207. PubMed ID: 10632361
[TBL] [Abstract][Full Text] [Related]
3. Morphologic conversion of a neuroblastoma-derived cell line by E6-mediated p53 degradation.
Gaitonde SV; Qi W; Falsey RR; Sidell N; Martinez JD
Cell Growth Differ; 2001 Jan; 12(1):19-27. PubMed ID: 11205742
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
5. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.
Sengupta S; Vonesch JL; Waltzinger C; Zheng H; Wasylyk B
EMBO J; 2000 Nov; 19(22):6051-64. PubMed ID: 11080152
[TBL] [Abstract][Full Text] [Related]
6. Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex.
Wolff A; Technau A; Ihling C; Technau-Ihling K; Erber R; Bosch FX; Brandner G
Oncogene; 2001 Mar; 20(11):1307-17. PubMed ID: 11313875
[TBL] [Abstract][Full Text] [Related]
7. Expression of C-terminal deleted p53 isoforms in neuroblastoma.
Goldschneider D; Horvilleur E; Plassa LF; Guillaud-Bataille M; Million K; Wittmer-Dupret E; Danglot G; de Thé H; Bénard J; May E; Douc-Rasy S
Nucleic Acids Res; 2006; 34(19):5603-12. PubMed ID: 17028100
[TBL] [Abstract][Full Text] [Related]
8. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
9. Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis.
Piacentini M; Piredda L; Starace DT; Annicchiarico-Petruzzelli M; Mattei M; Oliverio S; Farrace MG; Melino G
J Pathol; 1996 Dec; 180(4):415-22. PubMed ID: 9014863
[TBL] [Abstract][Full Text] [Related]
10. p53 determines multidrug sensitivity of childhood neuroblastoma.
Xue C; Haber M; Flemming C; Marshall GM; Lock RB; MacKenzie KL; Gurova KV; Norris MD; Gudkov AV
Cancer Res; 2007 Nov; 67(21):10351-60. PubMed ID: 17974978
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
[TBL] [Abstract][Full Text] [Related]
12. Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells.
Kurata K; Yanagisawa R; Ohira M; Kitagawa M; Nakagawara A; Kamijo T
Oncogene; 2008 Jan; 27(6):741-54. PubMed ID: 17653088
[TBL] [Abstract][Full Text] [Related]
13. NUB-7: a stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages.
Dimitroulakos J; Squire J; Pawlin G; Yeger H
Cell Growth Differ; 1994 Apr; 5(4):373-84. PubMed ID: 8043511
[TBL] [Abstract][Full Text] [Related]
14. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells.
Jasty R; Lu J; Irwin T; Suchard S; Clarke MF; Castle VP
Mol Genet Metab; 1998 Oct; 65(2):155-64. PubMed ID: 9787107
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
[TBL] [Abstract][Full Text] [Related]
16. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.
Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J
Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850
[TBL] [Abstract][Full Text] [Related]
17. Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents.
Gangopadhyay S; Jalali F; Reda D; Peacock J; Bristow RG; Benchimol S
Exp Cell Res; 2002 Apr; 275(1):122-31. PubMed ID: 11925110
[TBL] [Abstract][Full Text] [Related]
18. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
Satyamoorthy K; Chehab NH; Waterman MJ; Lien MC; El-Deiry WS; Herlyn M; Halazonetis TD
Cell Growth Differ; 2000 Sep; 11(9):467-74. PubMed ID: 11007451
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage.
Hartsell TL; Hinman LM; Hamann PR; Schor NF
J Pharmacol Exp Ther; 1996 May; 277(2):1158-66. PubMed ID: 8627528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
